Skip to main content

Muse Treatment Publishes New Clinical Resource Examining Integrated PTSD and Substance Abuse Treatment Through Evidence-Based Recovery Care

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
LOS ANGELES, CA - August 12, 2026 - PRESSADVANTAGE -

Muse Treatment has published a new educational resource exploring the relationship between post-traumatic stress disorder (PTSD) and substance use disorders, expanding its online library with clinically supported information designed to help patients and families better understand integrated treatment approaches. The article, "How PTSD and Substance Abuse Are Treated Together in Los Angeles," reviews current evidence-based practices for addressing co-occurring disorders while emphasizing the importance of coordinated behavioral healthcare that treats both conditions simultaneously rather than independently.

The publication arrives as healthcare organizations continue to recognize the close relationship between trauma and addiction. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), trauma exposure is common among people receiving behavioral healthcare, and untreated PTSD may contribute to substance use, relapse risk, and poorer treatment outcomes. The National Center for PTSD, part of the U.S. Department of Veterans Affairs, similarly reports that co-occurring PTSD and substance use disorders frequently require integrated treatment strategies that address both conditions concurrently to improve long-term recovery.

PTSD and Substance Abuse

The newly released educational resource explains that PTSD and addiction often reinforce one another. Some people begin using alcohol or drugs to temporarily reduce symptoms such as anxiety, intrusive memories, hypervigilance, or sleep disturbances, while ongoing substance use may worsen psychiatric symptoms over time. The article discusses how comprehensive clinical assessments help behavioral health professionals identify co-occurring conditions and develop individualized treatment plans that address both mental health and addiction throughout the recovery process.

The publication complements Muse Treatment's Los Angeles treatment resource, which outlines the organization's continuum of behavioral healthcare services. According to the organization's website, patients may receive medically supervised detoxification, psychiatric evaluation, dual-diagnosis treatment, medication management when clinically appropriate, family counseling, relapse prevention planning, trauma-informed behavioral therapies, and continuing recovery support. The website also describes multiple levels of care, including medically supervised detox, residential drug rehab programs, Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP), outpatient services, and aftercare planning that allow patients to transition through treatment based on ongoing clinical assessment.

This approach reflects recommendations published by the American Society of Addiction Medicine (ASAM), which advises that treatment intensity should be matched to each patient's medical, psychological, and social needs while providing continuity throughout recovery. SAMHSA also recommends integrated treatment for co-occurring disorders because addressing mental health conditions and substance use disorders together is associated with improved engagement, reduced relapse risk, and better long-term clinical outcomes compared with treating each condition separately.

The educational resource further explains that trauma-informed care has become an important component of modern behavioral healthcare. According to the National Institute of Mental Health (NIMH), PTSD is a treatable mental health condition, and evidence-based therapies, including Cognitive Behavioral Therapy (CBT) and other trauma-focused interventions, can significantly reduce symptoms when incorporated into individualized treatment plans. The publication describes how trauma-informed clinical practices seek to create safe therapeutic environments while helping patients develop healthy coping strategies that reduce reliance on alcohol or drugs.

For people searching online for drug rehab near me, the article provides educational guidance explaining how clinicians determine the appropriate level of care through comprehensive assessments rather than standardized treatment models. Patients experiencing both PTSD and substance use disorders may require medically supervised detoxification, structured residential treatment, outpatient behavioral healthcare, psychiatric services, or continuing recovery support depending on their medical history, symptom severity, and recovery goals. The publication emphasizes that individualized treatment planning remains central to evidence-based addiction medicine.

Muse Treatment also describes therapeutic services that may include Cognitive Behavioral Therapy, Dialectical Behavior Therapy, motivational interviewing, trauma-informed counseling, family therapy, psychiatric care, relapse prevention education, life-skills development, and treatment for co-occurring mental health disorders. According to the organization's website, treatment plans may also incorporate drug rehab with MAT (medication-assisted treatment) when clinically appropriate for opioid or alcohol use disorders, alongside behavioral therapies and medical supervision. This integrated model reflects current national recommendations supporting multidisciplinary care for complex behavioral health conditions.

People researching drug addiction treatment centers often compare providers based on the availability of comprehensive clinical services, evidence-based therapies, psychiatric expertise, and continuity across multiple levels of care. Muse Treatment's newest publication explains how coordinated treatment may include residential drug rehab programs, outpatient services, behavioral therapies, psychiatric support, and drug rehab with MAT (medication-assisted treatment) when medically indicated. The educational resource also recognizes that many people evaluating affordable drug rehab centers seek information that explains not only treatment availability but also the clinical principles that guide effective long-term recovery.

Research published by the National Institute on Drug Abuse (NIDA) consistently demonstrates that addiction is a chronic but treatable medical condition and that sustained engagement in evidence-based treatment is associated with improved recovery outcomes. National clinical guidance likewise supports integrated behavioral healthcare for people experiencing co-occurring mental health and substance use disorders, reinforcing the importance of coordinated care that addresses the full scope of a patient's clinical needs rather than isolated symptoms.

Patients and families throughout Westwood, Westwood Village, Little Holmby, Holmby Hills, Bel Air, Brentwood Glen, Sawtelle, Century City, and Cheviot Hills can access Muse Treatment's educational resources while learning about addiction and behavioral healthcare services available through its Los Angeles programs. By continuing to publish clinically informed content supported by nationally recognized healthcare organizations, Muse Treatment seeks to improve public understanding of PTSD, substance use disorders, trauma-informed care, and evidence-based recovery pathways. The organization's expanding educational library reflects an ongoing commitment to helping patients make informed treatment decisions while better understanding the role of integrated behavioral healthcare in supporting long-term recovery.

###

For more information about Muse Treatment, contact the company here:

Muse Treatment
David Rofofsky
(800) 426-1818
info@musetreatment.com
1251 Westwood Blvd, Los Angeles, CA 90024

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.28
-4.99 (-1.83%)
AAPL  302.25
-2.66 (-0.87%)
AMD  482.93
+8.61 (1.82%)
BAC  64.81
+0.81 (1.27%)
GOOG  342.37
-0.63 (-0.18%)
META  578.85
-20.27 (-3.38%)
MSFT  492.43
-11.38 (-2.26%)
NVDA  224.09
+6.59 (3.03%)
ORCL  153.28
+7.80 (5.36%)
TSLA  327.51
-5.30 (-1.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.